| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.92B | 1.93B | 1.91B | 1.58B | 1.32B |
| Gross Profit | 193.40M | 1.93B | 268.70M | 480.50M | 416.40M |
| EBITDA | 283.70M | 26.20M | 292.90M | 226.70M | 176.60M |
| Net Income | 107.50M | -185.70M | 139.60M | 154.40M | 90.00M |
Balance Sheet | |||||
| Total Assets | 1.74B | 1.83B | 2.11B | 2.10B | 1.79B |
| Cash, Cash Equivalents and Short-Term Investments | 259.20M | 290.60M | 231.00M | 155.60M | 248.30M |
| Total Debt | 410.30M | 428.90M | 391.80M | 368.90M | 22.10M |
| Total Liabilities | 1.19B | 1.20B | 1.18B | 1.13B | 746.70M |
| Stockholders Equity | 553.00M | 626.50M | 926.10M | 968.30M | 1.04B |
Cash Flow | |||||
| Free Cash Flow | 172.20M | 112.50M | 146.80M | 97.00M | 106.40M |
| Operating Cash Flow | 231.80M | 221.30M | 243.10M | 206.00M | 190.70M |
| Investing Cash Flow | -54.60M | 400.00K | -99.10M | -464.40M | -83.60M |
| Financing Cash Flow | -208.20M | -158.40M | -63.20M | 159.70M | -50.40M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | £635.66M | 34.51 | 11.27% | 1.58% | 23.91% | -14.66% | |
69 Neutral | £59.36B | 29.44 | 18.23% | 1.99% | 7.69% | 7.29% | |
68 Neutral | £2.60B | 24.45 | 19.34% | 2.00% | -0.47% | ― | |
63 Neutral | £1.49B | 30.83 | 13.12% | 1.64% | -2.53% | 22.25% | |
58 Neutral | £515.05M | 42.75 | 9.32% | 1.02% | 4.62% | 170.53% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
41 Neutral | £28.45M | -10.32 | 192.83% | ― | ― | ― |